Press release
Investigation over potential Wrongdoing announced for Investors who lost money with shares of DermTech, Inc. (NASDAQ: DMTK)
An investigation on behalf of investors in DermTech, Inc. (NASDAQ: DMTK) shares over possible breaches of fiduciary duty.
Investors who are current long term investors in DermTech, Inc. (NASDAQ: DMTK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: DMTK stocks follows a lawsuit filed against DermTech, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: DMTK stocks, concerns whether certain DermTech, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges that, the Defendants failed to disclose to investors that the Company experienced challenges with collections from commercial payors, that, as a result, there was a lower average selling price for DermTech's DMT, that, as a result of the foregoing, the Company's revenue growth would be adversely impacted, and that , as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation over potential Wrongdoing announced for Investors who lost money with shares of DermTech, Inc. (NASDAQ: DMTK) here
News-ID: 3542115 • Views: …
More Releases from Shareholders Foundation, Inc.
Investigation announced for Long-Term Investors in Sarepta Therapeutics, Inc. (N …
An investigation was announced for current long-term investors in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) concerning potential breaches of fiduciary duties by certain directors and officers of Sarepta Therapeutics, Inc.
Investors who are current long term investors in Sarepta Therapeutics, Inc. (NASDAQ: SRPT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
Lineage, Inc. (NASDAQ: LINE) Investor Alert: Deadline in Lawsuit on September 30 …
A deadline is coming up on September 30, 2025 in the lawsuit filed for certain investors of Lineage, Inc. (NASDAQ: LINE) over alleged securities laws violations by Lineage, Inc.
Investors who purchased shares of Lineage, Inc. (NASDAQ: LINE) have certain options and there are strict and short deadlines running. Deadline: September 30, 2025. NASDAQ: LINE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to…
Investigation announced for Investors in shares of Hims & Hers Health, Inc. (NYS …
An investigation was announced for long-term investors in shares of Hims & Hers Health, Inc. (NYSE: HIMS) concerning potential breaches of fiduciary duties by certain directors of Hims & Hers Health, Inc.
Investors who are current long term investors in Hims & Hers Health, Inc. (NYSE: HIMS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
Sable Offshore Corp. (NYSE: SOC) Investor Alert: Deadline in Lawsuit on Septembe …
A deadline is coming up on September 26, 2025 in the lawsuit filed for certain investors of Sable Offshore Corp. (NYSE: SOC) over alleged securities laws violations by Sable Offshore Corp.
Investors who purchased shares of Sable Offshore Corp. (NYSE: SOC) have certain options and there are strict and short deadlines running. Deadline: September 26, 2025. NYSE: SOC stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for DermTech
Europe Skin Cancer Diagnostics Market Trends & Outlook 2032
Based on Inkwood's report, the Europe Skin Cancer Diagnostics Market, encompassing countries such as Germany, Spain, France, Belgium, Poland, Italy, Nordic Countries, the United Kingdom, and the Rest of Europe, is poised for significant growth with a projected Compound Annual Growth Rate (CAGR) of 6.72% in revenue during the forecast period from 2023 to 2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/europe-skin-cancer-diagnostics-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
Leading the charge in this market are major companies…
Deadline on Dec. 15th coming up in Lawsuit for Investors in DermTech, Inc. (NASD …
A deadline is coming up on December 15, 2023 in the lawsuit filed for certain investors of DermTech, Inc. (NASDAQ: DMTK) over alleged securities laws violations by DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and there are strict and short deadlines running. Deadline: December 15, 2023. NASDAQ: DMTK stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Cancer Cell Biopsy Service Market Demand Will Increase to 2029 Evaluated By Glob …
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Cancer Cell Biopsy Service industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Cancer Cell Biopsy Service market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Cancer Cell Biopsy Service…
Lawsuit filed for certain Investors who lost money with shares of DermTech, Inc. …
An investor, who purchased shares of DermTech, Inc. (NASDAQ: DMTK), filed a lawsuit over alleged violations of Federal Securities Laws by DermTech, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2022, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2023. NASDAQ:…
Investigation announced for Investors in shares of DermTech, Inc. (NASDAQ: DMTK) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain DermTech directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Diego, CA based DermTech,…
Investigation announced for Investors who lost money with shares of DermTech, In …
An investigation was announced for investors of DermTech, Inc. (NASDAQ: DMTK) shares over potential securities laws violations by DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of DermTech, Inc. (NASDAQ: DMTK) concerning whether a series…
